Dysregulation of the nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) signaling pathway is a key feature of DKD pathophysiology. The gene discussed is SGCB; the disease is diabetic kidney disease.